Geron Corp (GERN) Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
Go back to Geron Corp (GERN) Announces Publication of IMbark Phase 2 Data in Journal of Clinical OncologyGeron Corp (NASDAQ: GERN) | Delayed: 3.32 +0.01 (0.30%) | |||||
---|---|---|---|---|---|---|
Previous Close | $3.31 | 52 Week High | $5.30 | |||
Open | $3.32 | 52 Week Low | $1.81 | |||
Day High | $3.34 | P/E | N/A | |||
Day Low | $3.27 | EPS | $-0.35 | |||
Volume | 3,589,686 |